Therapeutic Variation in Lowering Blood Pressure: Effects on Intracranial Pressure in Acute Intracerebral Haemorrhage

High Blood Press Cardiovasc Prev. 2021 Mar;28(2):115-128. doi: 10.1007/s40292-021-00435-z. Epub 2021 Feb 18.

Abstract

Introduction: Intracerebral haemorrhage (ICH) is associated with high morbidity and mortality. Blood pressure (BP) control is one of the main management strategies in acute ICH. Limited data currently exist regarding intracranial pressure (ICP) in acute ICH. The relationship between BP lowering and ICP is yet to be fully elucidated.

Methods: We conducted a systematic review to investigate the effects of BP lowering on ICP in acute ICH. The study protocol was registered on PROSPERO (CRD42019134470).

Results: Following PRISMA guidelines, MEDLINE, EMBASE and CENTRAL were searched for studies on ICH with BP and ICP or surrogate measures. 1096 articles were identified after duplicates were removed; 18 studies meeting the inclusion criteria. Dihydropyridine calcium channel blockers (CCBs) were the most common agent used to lower BP, but had a varying effect on ICP. Other BP-lowering agents used also had a varying effect on ICP.

Discussion and conclusion: Further work, including large observational or randomized interventional studies, is needed to develop a better understanding of the effect of BP lowering on ICP in acute ICH, which will assist the development of more effective management strategies.

Trial registration: The study protocol was registered on PROSPERO (CRD42019134470) on 29/05/2019.

Keywords: Blood pressure; Intervention; Intracerebral haemorrhage; Intracranial pressure; Stroke.

Publication types

  • Systematic Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects*
  • Cerebral Hemorrhage / diagnosis
  • Cerebral Hemorrhage / drug therapy*
  • Cerebral Hemorrhage / physiopathology
  • Female
  • Humans
  • Intracranial Pressure / drug effects*
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Substances

  • Antihypertensive Agents